Dr. Michael Aberman
Investor at Cure Ventures
About
An investor or advisor associated with the firm who is listed alongside XenImmune, a portfolio company focused on leveraging immune responses to target tumors.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Jeno Gyuris
Partner at Cure Ventures